Reversible fibroadenomatous mammary hyperplasia in male and female New Zealand white rabbits associated with cyclosporine a administration

Veterinary Pathology

Volumn 46, Issue 6, 2009, Pages 1144-1148

  Krimer, P M ^a   Harvey, S B ^a   Blas Machado, U ^a   Lauderdale, J D ^a   Moore, P A ^a  

^a UNIVERSITY OF GEORGIA   (United States)

Author keywords

Cyclosporine; Hyperplasia; Mammary glands; New Zealand white rabbits

Indexed keywords

ORYCTOLAGUS CUNICULUS;

CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT;

ANIMAL; ANIMAL DISEASE; ARTICLE; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; FEMALE; FIBROMA; HYPERTROPHY; MALE; PATHOLOGY; RABBIT; UDDER;

ADENOFIBROMA; ANIMALS; CYCLOSPORINE; FEMALE; HYPERTROPHY; IMMUNOSUPPRESSIVE AGENTS; MALE; MAMMARY GLANDS, ANIMAL; RABBITS;

EID: 75649109271     PISSN: 03009858     EISSN: 15442217     Source Type: Journal    
DOI: 10.1354/vp.08-VP-0314-K-CR     Document Type: Article

References (27)

1. Adamo PF, Rylander H, Adams WM: Ciclosporinuse in multi-drug therapy for meningoencephalomy-elitis of unknown aetiology in dogs. J Small Anim Pract 48:486-496, 2007
2. Baildam AD, Higgins RM, Hurley E, Furlong A, Walls J, Venning MC, Ackrill P, Mansel RE: Cyclosporin A and multiple fibroadenomas of thebreast. Br J Surg 83:1755-1757, 1996
3. Binokay F, Balal M, Demir E, Paydas S, Soyupak S, Sertdemir Y, Akgul E: Risk of developing fibroad-enoma with the use of cyclosporine A in renaltransplant recipients. Ren Fail 27:721-725, 2005
4. Ben-Jonathan N, LaPensee CR, LaPensee EW: What can we learn from rodents about prolactin inhumans? Endocr Rev 29:1-41, 2008
5. Bernard DJ, Maurizis JC, Sauvezie B, Bignon YJ, Chassagne J, Chollet P, Plagne R: Antagonism ofprolactin binding by cyclosporine A on MCF7breast tumour cell line. Anticancer Res 11:2147-2151,1991
6. Bole-Feysot C, Goffin V, Edery M, Binart N, Kelly PA: Prolactin (PRL) and its receptor: actions, signaltransduction pathways and phenotypes observed in PRL receptor knockout mice. Endocr Rev 19:225-268,1998
7. Borgmann AR, Bogle D, Robb CA, McDonald TO: Comparative toxicity of two-dexamethasone deriva-tives following topical ocular instillation to rabbits. II. Systemic histopathological changes. Toxicology 6:77-84, 1976
8. Brown RS, Beaver WT, Bottomley WK: On themechanism of drug-induced gingival hyperplasia. J Oral Pathol Med 20:201-209, 1991
9. Cantor LB, WuDunn D, Yung CW, Valluri S, Catoira YP, Hoop JS, Morgan LS: Ocular penetra-tion of levofloxacin, ofloxacin and ciprofloxacin ineyes with functioning filtering blebs: investigatormasked, randomised clinical trial. Br J Ophthalmol 92:345-347, 2008
10. Cardon SB, Larson DF, Russell DH: Rapidelevation of rat serum prolactin concentration bycyclosporine, a novel immunosuppressive drug. Biochem Biophys Res Commun 120:614-618, 1984
11. Ciavarella D, Guiglia R, Campisi G, Di Cosola M, Di Liberto C, Sabatucci A, Escudero N, Bascones A, Lo Muzio L: Update on gingival overgrowth bycyclosporine A in renal transplants. Med Oral Patol Oral Cir Bucal 12:E19-E25, 2007
12. Czock D, Keller F, Rasche FM, Häussler U: Pharmacokinetics and pharmacodynamics of sys-temically administered glucocorticoids. Clin Phar-macokinet 44 (1):61-98, 2005
13. Doose DR, Walker SA, Chien SC, Williams RR, Nayak RK: Levofloxacin does not alter cyclosporine disposition. J Clin Pharmacol 38:90-93, 1998
14. Iaria G, Urbani L, Catalano G, De Simone P, Carrai P, Petruccelli S, Morelli L, Coletti L, Garcia C, Liermann R, Mosca F, Filipponi F: Switch to tacrolimus for cyclosporine-induced gynecomastiain liver transplant recipients. Transplant Proc 37:2632-2633, 2005
15. Lam S, Partovi N, Ting LS, Ensom MH: Cortico-steroid interactions with cyclosporine, tacrolimus, mycophenolate, and sirolimus: fact or fiction? Ann Pharmacother 42:1037-1047, 2008
16. Lipman NS, Zhao ZB, Andrutis KA, Hurley RJ, Fox JG, White HJ: Prolactin-secreting pituitary adenomas with mammary dysplasia in New Zealand white rabbits. Lab Anim Sci 44:114-120, 1994
17. McLellan RA, Drobitch RK, Monshouwer M, Renton KW: Fluoroquinolone antibiotics inhibit cytochrome P450-mediated microsomal drug metab-olism in rat and human. Drug Metab Dispos 24:1134-1138, 1996
18. Nafar M, Ataie R, Einollahi B, Nematizadeh F, Firoozan A, Poorrezagholi F: A comparison be-tween the efficacy of systemic and local azithromycin therapy in treatment of cyclosporine induced gingi-val overgrowth in kidney transplant patients. Trans-plant Proc 35:2727-2728, 2003
19. Nam HS, McAnulty JF, Kwak HH, Yoon BI, Hyun C, Kim WH, Woo HM: Gingival overgrowth in dogs associated with clinically relevant cyclosporine blood levels: observations in a canine renal transplantationmodel. Vet Surg 37:247-253, 2008
20. Pan Y, Grindstaff A, Cassada D, Goldman M, Taylor J: Bilateral reduction mammoplasty in apatient treated with calcium channel blocker andcyclosporine after renal transplant: a case report. Transplantation 63:1032-1033, 1997
21. Petraitiene R, Petraitis V, Bacher J, Das SR, Parlow AF, Walsh TJ: Cyclosporine A-induced mammary hyperplasia and hyperprolactinemia in New Zealand White rabbits. Comp Med 51:430-435, 2001
22. Riesbeck K, Gullberg M, Forsgren A: Evidence thatthe antibiotic ciprofloxacin counteracts cyclospor-ine-dependent suppression of cytokine production. Transplantation 57:267-272, 1994
23. Sangalli L, Bortolotti A, Passerini F, Bonati M: Placental transfer, tissue distribution, and pharma-cokinetics of cyclosporine in the pregnant rabbit. Drug Metab Dispos 18:102-106, 1990
24. Seibel W, Yahia NA, McCleary LB, Lesko LJ, Hassell TM: Cyclosporine-induced gingival over-growth in beagle dogs. J Oral Pathol Med 18:240-245, 1989
25. Seo YL, Choi CS, Yoon DY, Yun EJ, Lee YJ, Park SJ, Moon JH, Cho SJ, Lee S, Han H, Kim SS, Lee JY: Benign breast diseases associated with cyclo-sporine therapy in renal transplant recipients. Transplant Proc 37:4315-4319, 2005
26. Shiu RP, Friesen HG: Mechanism of action ofprolactin in the control of mammary gland function. Annu Rev Physiol 42:83-96, 1980
27. Whalen RD, Tata PN, Burckart GJ, Venkataramanan R: Species differences in the hepatic and intestinal metabolism of cyclosporine. Xenobiotica 29:3-9, 1999